Dr. David J. Beyda, MD

Dr. Beyda practices at New Day Medical in Rego Park, New York.

Dr. Beyda's NPI, 1477716041, was assigned on July 3, 2008. Dr. Beyda graduated from Tel Aviv University Sackler in 2007. Dr. Beyda holds New York license 257492.

Dr. Beyda's primary practice is New Day Medical, at 97-12 63rd Dr, Rego Park, NY 11374 in Queens County. The practice phone is (718) 878-4656.

Dr. Beyda's primary practice is New Day Medical in Rego Park, New York. The medical group on file is Beyda Gastroenterology (Dr. David Beyda, MD). Dmand AI also links Dr. Beyda to 2 more group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beyda practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Beyda's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Beyda is board certified in gastroenterology by the American Board of Internal Medicine. Dr. Beyda is licensed in New York.

Dmand AI lists chronic anemia, chronic indigestion, chronic inflammatory bowel disease (IBD), gastroduodenitis, gastrointestinal bleeding, irritable bowel syndrome (IBS) and tobacco use among the conditions Dr. Beyda treats.

CMS data shows 669 Medicare services from Dr. Beyda across 9 procedure codes in 2024, for 282 Medicare patients. Medicare paid $106,656 for them. Every service was in an office.

CMS counts 282 Medicare patients who saw Dr. Beyda in 2024. The largest group is 65 to 74, with 150 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 0.95, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Beyda's median patient age at 57, with 41% women.

In 2024, Dr. Beyda wrote 551 Medicare Part D claims for 238 patients. 89% of them were for generic drugs. CMS names the drug for 493 of them, across 12 drugs with 11 or more claims each, at $59,531 in total drug cost. In 2023, CMS named 500 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 24 out of 100 for Dr. Beyda for performance year 2024, reported individually. Dr. Beyda accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 169 procedures of colonoscopy by Dr. Beyda, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Beyda in 2012. Dr. Beyda's most frequent co-author is Brett B. Bernstein, MD.

CMS Open Payments shows 62 general payments to Dr. Beyda from 11 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Abbvie Inc. paid the most, $359.

Dr. Beyda graduated from Tel Aviv University Sackler in 2007.

Dr. Beyda is in network with 13 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Massachusetts. Medicare plans come from the most carriers, 8. Check the plan with the practice before a visit.